AGO2 and non-small cell lung carcinoma: In contrast to the observed alterations in pS417‐AGO2 levels, the overall level of AGO2 protein remained relatively stable, indicating no significant changes between NSCLC and normal tissues (Figure S4G, Supporting Information).